CompletedPhase 4ACTRN12611000914965

The effect of routine reversal of neuromuscular blockade on surgical conditions for thyroid surgery

The effect of routine reversal using neostigmine, of neuromuscular blockade, on neuromuscular monitoring of the laryngeal nerve during thyroid surgery- a double blinded randomised control trial

Sponsor

Emma Boden

Enrollment

50 participants

Start Date

Aug 30, 2011

Study Type

Interventional

Conditions

Reversal of neuromuscular blockade during thyroid surgery

Summary

Participants will receive a standard anaesthetic with- propofol induction, remifentanil induction, 2x ED 95 (intubating conditions) atracurium 0.4mg/km, sevoflurane, dexamethasone and cefazolin. At 30 mins post induction patients will either get neostigmine/glycopyrrolate injection or saline injection prepared by an independent person, given by anaesthetist. Then the surgeon will determine, using the NIM stimulator whether the reversal of neuromuscular blockade is adequate.

Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 100 Yearss

Plain Language Summary

Simplified for easier understanding

This study examines whether routinely reversing the muscle-relaxing drugs used during thyroid surgery affects surgical conditions. It is open to adults aged 18 and older undergoing thyroid surgery at Peninsula Health. The study looks at whether allowing the neuromuscular blockade to wear off naturally versus actively reversing it makes a difference for the surgeon and patient outcomes.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Atracurium 0.4mg/kg given as an intubating dose, given intravenously as a bolus, then reversal at 30 mins with neostigmine 2.5mg and glycopyrrolate 0.4mg, intravenously as a bolus, if in the study arm

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000914965